All In Biotech

Free tool

FAERS Monitor: Lipitor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020702 or its brand name (Lipitor, Atorvastatin Calcium). Reports on generic versions are filed under their own applications.

Reports

248,656

Serious

160,978

65% of reports

Hospitalization

70,773

Death reported

18,815

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue14,464
  • drug ineffective13,345
  • nausea12,922
  • diarrhoea11,692
  • dyspnoea11,668
  • type 2 diabetes mellitus11,263
  • pain10,427
  • headache10,307
  • dizziness10,189
  • myalgia10,017
  • asthenia9,153
  • arthralgia8,830
  • pain in extremity8,371
  • fall8,134
  • death7,725

Reports by year received

View as table
YearReports
20045,709
20057,580
20068,146
20076,977
20086,528
20097,351
201014,619
201111,544
201213,815
201310,592
201415,345
201515,342
201614,718
201712,745
201812,859
201913,144
202012,183
202110,534
202210,498
20239,454
20249,967
202510,971
20268,029

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,805,503 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
type 2 diabetes mellitusSignal11,26342.041.1300,606
myalgiaSignal10,0175.25.132,538
pain in extremitySignal8,3712.42.47,037
fallSignal8,1342.12.04,607
astheniaSignal9,1532.12.05,136
arthralgia8,8301.81.83,217
dyspnoea11,6681.81.73,846
dizziness10,1891.71.73,238
fatigue14,4641.61.63,158
diarrhoea11,6921.51.52,255
pain10,4271.41.41,437
headache10,3071.41.41,179
nausea12,9221.41.41,428
drug ineffective13,3450.90.8346
death7,7250.80.7627

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.